Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)

Bibliography

• CBTRUS: (2000) CBTRUS. Statistical Report: Primary Brain Tumors in the United States. (1992-1997).
   Google Scholar
• OHGAKI H, KLEIHUES P: Epidemiology and etiology of gliomas. Acta Neuropathol. (Berl.) (2005) 109(1):93-108.
   PubMed Web of Science ®Google Scholar
• LAWS ER, PARNEY IF, HUANG W et al.: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J. Neurosurg. (2003) 99(3):467-473.
   Google Scholar
• JOHANNESEN TB, LANGMARK F, LOTE K: Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J. Neurosurg. (2003) 99(5):854-862.
   PubMed Web of Science ®Google Scholar
• JEREMIC B, MILICIC B, GRUJICIC D et al.: Clinical prognostic factors in patients with malignant glioma treated with combined modality approach. Am. J. Clin. Oncol. (2004) 27(2):195-204.
   PubMed Web of Science ®Google Scholar
• BUCKNER JC: Factors influencing survival in high-grade gliomas. Semin. Oncol. (2003) 30(6 Suppl. 19):10-14.
   PubMed Web of Science ®Google Scholar
• KELLY PJ, DAUMAS-DUPORT C, KISPERT DB et al.: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J. Neurosurg. (1987) 66(6):865-874.
   PubMed Web of Science ®Google Scholar
• GRIEB P: [5-Aminolevulinic acid (ALA) and its applications in neurosurgery]. Neurol. Neurochir. Pol. (2004) 38(3):201-207.
   PubMedGoogle Scholar
• STUMMER W, NOVOTNY A, STEPP H et al.: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J. Neurosurg. (2000) 93(6):1003-1013.
   PubMed Web of Science ®Google Scholar
• GORBACH AM, HEISS JD, KOPYLEV L, OLDFIELD EH: Intraoperative infrared imaging of brain tumors. J. Neurosurg. (2004) 101(6):960-969.
   PubMed Web of Science ®Google Scholar
• WITWER BP, MOFTAKHAR R, HASAN KM et al.: Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm. J. Neurosurg. (2002) 97(3):568-575.
   PubMed Web of Science ®Google Scholar
• SAWAYA R: Extent of resection in malignant gliomas: a critical summary. J. Neurooncol. (1999) 42(3):303-305.
   PubMed Web of Science ®Google Scholar
• BUCCI MK, MAITY A, JANSS AJ et al.: Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era. Cancer (2004) 101(4):817-824.
   PubMed Web of Science ®Google Scholar
• FISCHBACH AJ, MARTZ KL, NELSON JS et al.: Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies. Am. J. Clin. Oncol. (1991) 14(5):365-370.
   PubMed Web of Science ®Google Scholar
• SHORT SC: External beam and conformal radiotherapy in the management of gliomas. Acta Neurochir. Suppl. (2003) 88:37-43.
   PubMedGoogle Scholar
• GROSSMAN SA, BATARA JF: Current management of glioblastoma multiforme. Semin. Oncol. (2004) 31(5):635-644.
   PubMed Web of Science ®Google Scholar
• SHAPIRO WR, SHAPIRO JR: Biology and treatment of malignant glioma. Oncology (Huntingt.) (1998) 12(2):233-240; discussion 240, 246.
   PubMed Web of Science ®Google Scholar
• STUPP R, MASON WP, VAN DEN BENT MJ et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. (2005) 352(10):987-996.
   PubMed Web of Science ®Google Scholar
• BREM H, PIANTADOSI S, BURGER PC et al.: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet (1995) 345(8956):1008-1012.
   PubMed Web of Science ®Google Scholar
• BREM H, GABIKIAN P: Biodegradable polymer implants to treat brain tumors. J. Control. Release (2001) 74(1-3):63-67.
   PubMed Web of Science ®Google Scholar
• WESTPHAL M, LAMSZUS K, HILT D: Intracavitary chemotherapy for glioblastoma: present status and future directions. Acta Neurochir. Suppl. (2003) 88:61-67.
   PubMedGoogle Scholar
• GURURANGAN S, COKGOR L, RICH JN et al.: Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro-oncol. (2001) 3(4):246-250.
   PubMed Web of Science ®Google Scholar
• GARFIELD J, DAYAN AD, WELLER RO: Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU. Clin. Oncol. (1975) 1(3):213-222.
   PubMedGoogle Scholar
• KLATZMANN D, VALERY CA, BENSIMON G et al.: A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum. Gene Ther. (1998) 9(17):2595-2604.
   PubMed Web of Science ®Google Scholar
• RAINOV NG: A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. (2000) 11(17):2389-2401.
   PubMed Web of Science ®Google Scholar
• SHAND N, WEBER F, MARIANI L et al.: A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum. Gene Ther. (1999) 10(14):2325-2335.
   PubMed Web of Science ®Google Scholar
• TRASK TW, TRASK RP, AGUILAR-CORDOVA E et al.: Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol. Ther. (2000) 1(2):195-203.
   PubMed Web of Science ®Google Scholar
• HASSENBUSCH SJ, NARDONE EM, LEVIN VA, LEEDS N, PIETRONIGRO D: Stereotactic injection of DTI-015 into recurrent malignant gliomas: phase I/II trial. Neoplasia (2003) 5(1):9-16.
   PubMed Web of Science ®Google Scholar
• NEUWELT EA, DAHLBORG SA: Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases. J. Neurooncol. (1987) 4(3):195-207.
   PubMed Web of Science ®Google Scholar
• BLACK KL, CLOUGHESY T, HUANG SC et al.: Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J. Neurosurg. (1997) 86(4):603-609.
   PubMed Web of Science ®Google Scholar
• TFAYLI A, HENTSCHEL P, MADAJEWICZ S et al.: Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J. Neurooncol. (1999) 42(1):73-77.
   PubMed Web of Science ®Google Scholar
• MADAJEWICZ S, CHOWHAN N, ILIYA A et al.: Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer (1991) 67(11):2844-2849.
   PubMed Web of Science ®Google Scholar
• FEUN LG, LEE YY, YUNG WK, SAVARAJ N, WALLACE S: Intracarotid VP-16 in malignant brain tumors. J. Neurooncol. (1987) 4(4):397-401.
   PubMed Web of Science ®Google Scholar
• GREENBERG HS, ENSMINGER WD, CHANDLER WF et al.: Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J. Neurosurg. (1984) 61(3):423-429.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN DM, LASKE DW, MORRISON PF, BANKIEWICZ KS, OLDFIELD EH: Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J. Neurosurg. (1995) 82(6):1021-1029.
   PubMed Web of Science ®Google Scholar
• GILLIES GT, SMITH JH, HUMPHREY JA, BROADDUS WC: Positive pressure infusion of therapeutic agents into brain tissues: mathematical and experimental simulations. Technol. Health Care (2005) 13(4):235-243.
   PubMedGoogle Scholar
• HADACZEK P, KOHUTNICKA M, KRAUZE MT et al.: Convection-enhanced delivery of adeno-associated virus type 2(AAV2) into the striatum and transport of AAV2 within monkey brain. Hum. Gene Ther. (2006) 17(3):291-302.
   PubMed Web of Science ®Google Scholar
• KUNWAR S: Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies. Acta Neurochir. Suppl. (2003) 88:105-111.
   PubMedGoogle Scholar
• LESNIAK MS, BREM H: Targeted therapy for brain tumours. Nat. Rev. Drug Discov. (2004) 3(6):499-508.
   PubMed Web of Science ®Google Scholar
• LIDAR Z, MARDOR Y, JONAS T et al.: Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J. Neurosurg. (2004) 100(3):472-479.
   PubMed Web of Science ®Google Scholar
• MURO K, DAS S, RAIZER JJ: Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas. Technol. Cancer Res. Treat. (2006) 5(3):201-213.
   PubMed Web of Science ®Google Scholar
• LASKE DW, ROSSI P: Phase II multicenter trial of intratumoral/interstitial therapy with TransMID in patients with refractory and progressive glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA). Neuro-oncol. (2002) 4(Suppl. 2):558.
   Google Scholar
• RUSTAMZADEH E, HALL WA, TODHUNTER DA et al.: Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice. Int. J. Cancer (2007) 120(2):411-419.
   PubMed Web of Science ®Google Scholar
• KUAN CT, WIKSTRAND CJ, BIGNER DD: EGFRvIII as a promising target for antibody-based brain tumor therapy. Brain Tumor Pathol. (2000) 17(2):71-78.
   PubMedGoogle Scholar
• RAVIC M: Intracavitary treatment of malignant gliomas: radioimmunotherapy targeting fibronectin. Acta Neurochir. Suppl. (2003) 88:77-82.
   PubMedGoogle Scholar
• REARDON DA, AKABANI G, COLEMAN RE et al.: Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J. Clin. Oncol. (2002) 20(5):1389-1397.
   PubMed Web of Science ®Google Scholar
• AKABANI G, REIST CJ, COKGOR I et al.: Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors. J. Nucl. Med. (1999) 40(4):631-638.
   PubMed Web of Science ®Google Scholar
• HOPKINS K, CHANDLER C, EATOUGH J, MOSS T, KEMSHEAD JT: Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose. Int. J. Radiat. Oncol. Biol. Phys. (1998) 40(4):835-844.
   PubMed Web of Science ®Google Scholar
• RIVA P, FRANCESCHI G, FRATTARELLI M et al.: Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study. Clin. Cancer Res. (1999) 5(10 Suppl.):3275s-3280s.
   PubMed Web of Science ®Google Scholar
• ULLRICH N, BORDEY A, GILLESPIE GY, SONTHEIMER H: Expression of voltage-activated chloride currents in acute slices of human gliomas. Neuroscience (1998) 83(4):1161-1173.
   PubMed Web of Science ®Google Scholar
• SOROCEANU L, GILLESPIE Y, KHAZAELI MB, SONTHEIMER H: Use of chlorotoxin for targeting of primary brain tumors. Cancer Res. (1998) 58(21):4871-4879.
   PubMed Web of Science ®Google Scholar
• ULLRICH N, GILLESPIE GY, SONTHEIMER H: Human astrocytoma cells express a unique chloride current. Neuroreport (1996) 7(5):1020-1024.
   PubMed Web of Science ®Google Scholar
• ULLRICH N, SONTHEIMER H: Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am. J. Physiol. (1996) 270(5 Pt 1):C1511-C1521.
   PubMed Web of Science ®Google Scholar
• LYONS SA, O'NEAL J, SONTHEIMER H: Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia (2002) 39(2):162-173.
   PubMed Web of Science ®Google Scholar
• SOROCEANU L, MANNING TJ, Jr., SONTHEIMER H: Modulation of glioma cell migration and invasion using Cl(-) and K(+) ion channel blockers. J. Neurosci. (1999) 19(14):5942-5954.
   PubMed Web of Science ®Google Scholar
• DESHANE J, GARNER CC, SONTHEIMER H: Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. (2003) 278(6):4135-4144.
   PubMed Web of Science ®Google Scholar
• MCFERRIN MB, SONTHEIMER H: A role for ion channels in glioma cell invasion. Neuron Glia Biol. (2006) 2(1):39-49.
   PubMed Web of Science ®Google Scholar
• MAMELAK AN, MORGAN R, RAUBITSCHEK A et al.: Phase I/II trial of intracavitary 131I-TM-601 in adult patients with recurrent high grade glioma. Neuro-oncol. (2003) Abstr. RA-19.
   Google Scholar
• HOCKADAY DC, SHEN S, FIVEASH J et al.: Imaging glioma extent with 131I-TM-601. J. Nucl. Med. (2005) 46(4):580-586.
   PubMed Web of Science ®Google Scholar